Public list: BIO 2016 (619) Smart Money VCs (6328) Pharma Startups (4732) Cancer Therapeutics (1137)

Zai Lab (再鼎医药) (NASDAQ: ZLAB) focuses on discovering, developing and commercializing a pipeline comprised of antibody-based therapies and other protein-based therapeutics that modulates the immune system or directly target tumors. The company's programs are specifically aimed at patient populations with high unmet medical need-including many under-served indications specific to the Asian region.

Zai Lab (再鼎医药) (NASDAQ: ZLAB) focuses on discovering, developing and commercializing a pipeline comprised of antibody-based therapies and other protein-based therapeutics that modulates the immune system or directly target tumors. The company...Show all

Company (IPO / Went public)

Phone: +86 21 6163 2588

Fax:

Zhangjiang Hi-tech Park, Pudong
1043 Halei Road, Building 8, Suite 502
Shanghai, 201203
Shanghai, China

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Zai Lab $310M Sep 20, 2017

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Zai Lab Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 10 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)